300639 凯普生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-5.6032.87642.60930.51620.889
总资产报酬率 ROA (%)-4.8422.25431.46024.04417.461
投入资产回报率 ROIC (%)-5.4342.76440.12528.79320.296

边际利润分析
销售毛利率 (%)53.81461.02969.36467.63373.366
营业利润率 (%)-74.8603.85739.18540.17134.614
息税前利润/营业总收入 (%)-77.7672.29137.96839.69334.048
净利润/营业总收入 (%)-65.6656.20332.19333.10629.137

收益指标分析
经营活动净收益/利润总额(%)14.86517.449130.114103.498101.699
价值变动净收益/利润总额(%)-1.91337.8701.0031.9491.148
营业外收支净额/利润总额(%)0.789-15.710-3.069-1.570-1.048

偿债能力分析
流动比率 (X)6.5496.2553.2293.7676.475
速动比率 (X)6.3186.0593.1423.5506.157
资产负债率 (%)10.04110.95122.45417.8750.113
带息债务/全部投入资本 (%)1.8320.7292.2614.5183.253
股东权益/带息债务 (%)5,268.51013,367.9604,194.7152,062.4722,949.580
股东权益/负债合计 (%)877.619775.256324.196422.329740.824
利息保障倍数 (X)33.635-2.198-755.637278.471-165.019

营运能力分析
应收账款周转天数 (天)721.189751.262123.204113.309120.417
存货周转天数 (天)89.72291.29127.91150.64969.714